Using real-world data for post-market surveillance of drug safety After a therapeutic drug hits the market, it is crucial to continuously gather, analyze, and report data regarding its safety […] November 15, 2023 · Janssen Pharmaceutica
Looking forward: Azalea Vision's smart lens is a game-changer for ocular disorders January 24, 2024 · BioVox
Key steps for impactful communication New advances in the life sciences shouldn’t be kept in the dark. Whether you are an academic publishing a paper, […] November 15, 2023 · BioVox
Bridging the immunity gap: improving animal welfare without antibiotics February 21, 2024 · V-Bio Ventures
How the Chair of the Board can empower a first-time biotech CEO January 19, 2024 · V-Bio Ventures
The rise of women’s health It’s been a Barbie world this summer with crowds of pink-clad moviegoers flooding the cinemas. Simultaneously, we’ve been witnessing a […] November 15, 2023 · V-Bio Ventures
Muna Therapeutics: hopeful solutions for memory loss Muna Therapeutics is developing transformative therapies for neurodegenerative diseases. These drugs aim to preserve cognition and enhance the brain’s resilience […] October 17, 2023 · V-Bio Ventures
One event, uniting Belgium’s regions BioWin and MEDVIA are two Belgian organizations which support and promote health innovation in Wallonia and Flanders. This year, these […] October 17, 2023 · Janssen Pharmaceutica
Intelligent dentistry: AI is making surgeries safer The AIPLANT project aims to reduce complications from dental implant surgery using AI-based preoperative planning. The project is a collaboration […] October 17, 2023 · MEDVIA
Health data standardization: What FHIR can do for you! Patient data is a treasure trove of information, vital to tailoring individual care pathways and generating profound insights to enhance […] October 17, 2023 · Janssen Pharmaceutica
QbD Chair for Precision Oncology Research in Glioblastoma extended for three years The QbD Chair supports the research of Professor Frederik De Smet on glioblastoma, an aggressive form of brain cancer. Behind […] January 22, 2024 · Press Release
V-Bio Ventures portfolio company Agomab raises $100 million Series C to advance fibrosis-focused pipeline — Round led by Fidelity Management & Research Company with participation from new investors EQT Life Sciences, Canaan and Dawn […] October 11, 2023 · V-Bio Ventures
V-Bio Ventures portfolio company Protealis secures EUR 22 million in oversubscribed B round funding to propel sustainable plant protein seed solutions Ghent, 23 January 2024 – Protealis, a leading innovator in seed solutions for sustainable plant proteins based in Ghent, Belgium, […] January 23, 2024 · V-Bio Ventures
V-Bio Ventures-funded Tanai Therapeutics develops first-in-class therapeutics for obesity Ghent, 6 December 2023 – VIB, Flanders’ leading life sciences institute, together with lead investor V-Bio Ventures has launched a […] December 6, 2023 · V-Bio Ventures